OA05.07 Prognostic value of circulating tumor cells in limited-disease small cell lung cancer patients treated on the CONVERT Trial.
Authors
Fernandez-Gutierrez, FabiolaFoy, Victoria
Burns, Katy
Pierce, Jackie
Morris, Karen
Priest, Lynsey
Tugwood, Jonathan D
Ashcroft, Linda
Faivre-Finn, Corinne
Dive, Caroline
Blackhall, Fiona H
Affiliation
Clinical & Experimental Pharmacology Group, CRUK Manchester Institute, Manchester, United KingdomIssue Date
2017-01
Metadata
Show full item recordCitation
OA05.07 Prognostic value of circulating tumor cells in limited-disease small cell lung cancer patients treated on the CONVERT Trial. 2017, 12 (1):S263 Journal of Thoracic OncologyJournal
Journal of Thoracic OncologyDOI
10.1016/j.jtho.2016.11.255Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S1556086416314964Type
Meetings and ProceedingsLanguage
enISSN
15560864ae974a485f413a2113503eed53cd6c53
10.1016/j.jtho.2016.11.255